Multiple Sclerosis News Today Forums Forums Trials and Research FDA to Review Treatment for Relapsing Forms of MS

  • FDA to Review Treatment for Relapsing Forms of MS

    Posted by ms-news-today-moderator on March 21, 2019 at 8:11 am

    The U.S. Food and Drug Administration (FDA) has agreed to review Alkermes’ request to approve diroximel fumarate (BIIB098) as a treatment for relapsing forms of multiple sclerosis (MS), the company announced.

    A final decision by the FDA is expected in the fourth quarter of 2019. If approved, diroximel fumarate likely will be marketed in the U.S. with the brand name Vumerity. Click here to find out more.

    Did you know about this? What are your thoughts on this news?

    replied 5 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.